loadpatents
name:-0.0055899620056152
name:-0.006558895111084
name:-0.00043702125549316
Baeyens; Jose Manuel Patent Filings

Baeyens; Jose Manuel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Baeyens; Jose Manuel.The latest application filed is for "use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy".

Company Profile
0.5.5
  • Baeyens; Jose Manuel - Granada ES
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
Grant 11,419,873 - Buschmann , et al. August 23, 2
2022-08-23
Use Of Sodium Channel Blockers For The Treatment Of Neuropathic Pain Developing As A Consequence Of Chemotherapy
App 20210252004 - Buschmann; Helmut Heinrich ;   et al.
2021-08-19
Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
Grant 10,624,896 - Buschmann , et al.
2020-04-21
Use Of Sodium Channel Blockers For The Treatment Of Neuropathic Pain Developing As A Consequence Of Chemotherapy
App 20190160074 - Buschmann; Helmut Heinrich ;   et al.
2019-05-30
Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
Grant 10,149,852 - Buschmann , et al. Dec
2018-12-11
Use Of Sodium Channel Blockers For The Treatment Of Neuropathic Pain Developing As A Consequence Of Chemotherapy
App 20170000797 - Buschmann; Helmut Heinrich ;   et al.
2017-01-05
Use Of Sodium Channel Blockers For The Treatment Of Neuropathic Pain Developing As A Consequence Of Chemotherapy
App 20150283140 - Buschmann; Helmut Heinrich ;   et al.
2015-10-08
Use of sodium channel blockers for the treatment of neuropathic pain developing as a consequence of chemotherapy
Grant 9,018,222 - Buschmann , et al. April 28, 2
2015-04-28
Use Of Sodium Channel Blockers For The Treatment Of Neuropathic Pain Developing As A Consequence Of Chemotherapy
App 20100215771 - Buschmann; Helmut Heinrich ;   et al.
2010-08-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed